Rivaroxaban Modulates TLR4/Myd88/NF-Kß Signaling Pathway in a Dose-Dependent Manner With Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression.

Abdelzaher, Walaa Yehia; Mohammed, Hanaa H; Welson, Nermeen N; Batiha, Gaber El-Saber; Baty, Roua S; Abdel-Aziz, Asmaa Mohamed

Abdelzaher, Walaa Yehia; Mohammed, Hanaa H; Welson, Nermeen N; Batiha, Gaber El-Saber; Baty, Roua S; Abdel-Aziz, Asmaa Mohamed.

Afiliação

Abdelzaher WY; Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt.
Mohammed HH; Department of Histology, Faculty of Medicine, Minia University, Minia, Egypt.
Welson NN; Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.
Baty RS; Department of Biotechnology, College of Science, Taif University, Taif, Saudi Arabia.
Abdel-Aziz AM; Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt.

Front Pharmacol ; 12: 715354, 2021.

Article em En | MEDLINE | ID: mdl-34630092

Palavras-chave

MyD88; NF-kß; TLR4; depression; rivaroxban

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article